Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

135 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Outcomes of Patients With Treated Secondary Acute Myeloid Leukemia: A High-Risk Subtype That Warrants an Independent Prognostic Designation.
Senapati J, Kantarjian HM, Haddad FG, Short NJ, Borthakur G, Kanagal-Shamanna R, Tang G, Jabbour E, DiNardo CD, Daver N, Montalban-Bravo G, Shah V, Alousi A, Shpall E, Popat U, Garcia-Manero G, Ravandi F, Kadia TM. Senapati J, et al. Among authors: montalban bravo g. Am J Hematol. 2024 Dec 24. doi: 10.1002/ajh.27561. Online ahead of print. Am J Hematol. 2024. PMID: 39718824
Artificial Intelligence Assessment of Chest Radiographs for COVID-19.
Sasaki K, Garcia-Manero G, Nigo M, Jabbour E, Ravandi F, Wierda WG, Jain N, Takahashi K, Montalban-Bravo G, Daver NG, Thompson PA, Pemmaraju N, Kontoyiannis DP, Sato J, Karimaghaei S, Soltysiak KA, Raad II, Kantarjian HM, Carter BW; D3CODE Research Team. Sasaki K, et al. Among authors: montalban bravo g. Clin Lymphoma Myeloma Leuk. 2024 Nov 29:S2152-2650(24)02435-2. doi: 10.1016/j.clml.2024.11.013. Online ahead of print. Clin Lymphoma Myeloma Leuk. 2024. PMID: 39710565
Diagnostic challenges of high-grade myeloid malignancies with partial plasmacytoid dendritic cell differentiation: report of two cases with literature review.
Nahmod KA, Miranda RN, Vega F, Thakral B, Pemmaraju N, Montalban-Bravo G, Loghavi S, Jelloul FZ, Wang W, Wang S, Muzzafar T, Patel K, Bueso-Ramos CE, Medeiros LJ, Kanagal-Shamanna R. Nahmod KA, et al. Among authors: montalban bravo g. Leuk Lymphoma. 2024 Dec 20:1-9. doi: 10.1080/10428194.2024.2422846. Online ahead of print. Leuk Lymphoma. 2024. PMID: 39704386
Clinical interrogation of TP53 aberrations and its impact on survival in patients with myeloid neoplasms.
Senapati J, Loghavi S, Garcia-Manero G, Tang G, Kadia T, Short NJ, Abbas HA, Arani N, DiNardo CD, Borthakur G, Pemmaraju N, Oran B, Shpall E, Popat U, Champlin R, Pierce S, Arora S, Issa G, Yilmaz M, Patel K, Takahashi K, Montalban-Bravo G, Hammond D, Haddad FG, Ravandi F, Kantarjian HM, Daver NG. Senapati J, et al. Among authors: montalban bravo g. Haematologica. 2024 Dec 12. doi: 10.3324/haematol.2024.286465. Online ahead of print. Haematologica. 2024. PMID: 39665206 Free article.
Cladribine-Based Therapy for Acute Myeloid Leukemia in Child, Adolescent, and Early Young Adult Patients: The MD Anderson Cancer Center Experience.
McCall D, Alqahtani S, Budak M, Sheikh I, Fan AE, Ramakrishnan R, Nunez C, Roth M, Garcia MB, Gibson A, Daver N, Garces S, Short NJ, Issa GC, Ravandi F, DiNardo CD, Montalban Bravo G, Garcia-Manero G, Cuglievan B, Kadia T. McCall D, et al. Among authors: montalban bravo g. Cancers (Basel). 2024 Nov 20;16(22):3886. doi: 10.3390/cancers16223886. Cancers (Basel). 2024. PMID: 39594839 Free PMC article.
Long-term follow-up of a phase 2 study of all-trans retinoic acid, arsenic trioxide, and gemtuzumab ozogamicin in acute promyelocytic leukemia.
Jen WY, Marvin-Peek J, Kantarjian HM, Alvarado Y, Borthakur G, Jabbour E, Wierda W, Kadia TM, Daver NG, DiNardo CD, Short NJ, Jain N, Ferrajoli A, Kornblau S, Yilmaz M, Ohanian M, McCue D, Burger J, Hammond D, Patel K, Issa GC, Pemmaraju N, Sasaki K, Maiti A, Abbas HA, Chien K, Takahashi K, Haddad F, Bose P, Masarova L, Montalban-Bravo G, Swaminathan M, Brandt M, Pierce S, Garcia-Manero G, Ravandi F. Jen WY, et al. Among authors: montalban bravo g. Cancer. 2024 Nov 25. doi: 10.1002/cncr.35662. Online ahead of print. Cancer. 2024. PMID: 39584789
A phase II trial of ipilimumab, nivolumab, or ipilimumab and nivolumab with or without azacitidine in relapsed or refractory myelodysplastic neoplasms.
Bouligny IM, Montalban-Bravo G, Sasaki K, Daver N, Jabbour E, Alvarado Y, DiNardo CD, Ravandi F, Borthakur G, Pemmaraju N, Kadia T, Masarova L, Takahashi K, Andreeff M, Bazinet A, Yang H, Kanagal R, Pierce S, Meyer M, Huang X, Garcia-Manero G. Bouligny IM, et al. Among authors: montalban bravo g. Leukemia. 2024 Nov 17. doi: 10.1038/s41375-024-02457-7. Online ahead of print. Leukemia. 2024. PMID: 39551874 No abstract available.
Outcomes of patients with acute myeloid leukemia and bone marrow fibrosis.
Urrutia S, Kantarjian HM, Ravandi-Kashani F, Bueso-Ramos C, Kanagal-Shamanna R, Jabbour E, Montalban-Bravo G, Short NJ, Daver N, Borthakur G, Dinardo CD, Kadia TM, Masarova L, Bose P, Pemmaraju N, Garcia-Manero G, Sasaki K. Urrutia S, et al. Among authors: montalban bravo g. J Hematol Oncol. 2024 Nov 15;17(1):112. doi: 10.1186/s13045-024-01630-w. J Hematol Oncol. 2024. PMID: 39548557 Free PMC article.
The IL-1β inhibitor canakinumab in previously treated lower-risk myelodysplastic syndromes: a phase 2 clinical trial.
Rodriguez-Sevilla JJ, Adema V, Chien KS, Loghavi S, Ma F, Yang H, Montalban-Bravo G, Huang X, Calvo X, Joseph J, Bodden K, Garcia-Manero G, Colla S. Rodriguez-Sevilla JJ, et al. Among authors: montalban bravo g. Nat Commun. 2024 Nov 13;15(1):9840. doi: 10.1038/s41467-024-54290-2. Nat Commun. 2024. PMID: 39537648 Free PMC article. Clinical Trial.
Causes of death in patients with myelodysplastic syndrome and spliceosome mutations.
Kontoyiannis PD, Peddireddy AS, Sasaki K, Chien K, Senapati J, Montalban-Bravo G, DiNardo C, Borthakur G, Kanagal-Shamanna R, Bueso-Ramos C, Pierce S, Kantarjian H, Garcia-Manero G, Urrutia S. Kontoyiannis PD, et al. Among authors: montalban bravo g. Leuk Res. 2024 Dec;147:107612. doi: 10.1016/j.leukres.2024.107612. Epub 2024 Nov 6. Leuk Res. 2024. PMID: 39536685 No abstract available.
135 results